TRXD - Trxade Group, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.4500
-0.0400 (-2.68%)
At close: 2:01PM EDT
Stock chart is not supported by your current browser
Previous Close1.4900
Open1.4800
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.2845 - 1.4800
52 Week Range0.2300 - 1.5000
Volume1,675
Avg. Volume3,312
Market Cap51.803M
Beta (3Y Monthly)1.41
PE Ratio (TTM)483.33
EPS (TTM)0.0030
Earnings DateNov 3, 2016 - Nov 4, 2016
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.70
Trade prices are not sourced from all markets
  • MoneyShow

    Trxade Eyes B2B in Pharmacies

    Faris Sleem, editor of The Bowser Report, is a leading specialist in low-priced, micro-cap stocks; indeed, his latest featured recommendation had 2018 revenues of just $3.8 million.

  • GlobeNewswire

    Trxade Group Generates Record Revenues in Second Quarter 2019

    Revenue Growth of 129% to $1.9 MillionOperating Income Growth of 322% to $132,7051st Half 2019 EPS of $0.01 TAMPA, FL, July 29, 2019 -- Trxade Group, Inc. (OTCQB: TRXD), an.

  • GlobeNewswire

    TRXADE GROUP, INC, S-1 REGISTRATION DECLARED EFFECTIVE

    Trxade Group, Inc. (TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacies and drug manufacturers, MSO with a specialty pharmacy, and a warehouse and drug delivery service for consumers. Trxade is pleased to announce that the registration statement on Form S-1 (the "S-1 Registration Statement") previously filed with the Securities and Exchange Commission (the "SEC") was declared effective by the SEC today, July 2nd, 2019. This S-1 Registration Statement covers the resale from time to time by the selling shareholders identified in the S-1 Registration Statement for up to 31,949,712 shares of our common stock.

  • GlobeNewswire

    TRXADE GROUP SUBSIDIARY COMMUNITY SPECILAITY PHARMACY PASSES RIGOROUS REVIEW PROCESS TO EARN LEGITSCRIPT CERTIFICATION

    Trxade Group, Inc. (TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacists and drug manufacturers, MSO with a Specialty pharmacy. Trxade has warehouse and drug delivery services for consumers further advanced capabilities today by announcing that company’s subsidiary Community Specialty Pharmacy (https://www.comsprx.com ) has secured its certification with LegitScript.

  • ACCESSWIRE

    Trxade Group Achieves Record First Quarter 2019 Financial Results Driven By An Increase In Revenues

    First Quarter Highlights: Company achieves record revenues of $1.512 million in quarter ending March 31, 2019 an increase from $852,923 in quarter ending March 31, 2018 Operating Income Increased to $171,759 ...

  • GlobeNewswire

    Coverage Initiated for Trxade Group Inc. via NetworkNewsWire

    NEW YORK, April 23, 2019 -- via NetworkWire - Trxade Group Inc. (OTCQB: TRXD), an integrated drug purchasing and delivery platform that enables trade among healthcare buyers.

  • GlobeNewswire

    Trxade Group, Inc. Reports Fourth Quarter and Full Year 2018 Results

    TAMPA, Fla., March 26, 2019 -- Trxade Group, Inc., (OTCQB: TRXD) is an integrated drug purchasing and delivery solutions company with a market platform that enables trade among.

  • GlobeNewswire

    Trxade Group Launches its MSO Pharmacy Network and Surpasses 10,000 Independent Retail Pharmacy Members

    Expected to Drive Revenue Growth in 2019 TAMPA, FL, Feb. 25, 2019 -- February 25, 2019 – Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated drug.

  • GlobeNewswire

    Trxade Group to Exhibit its Trading Procurement Platform for Healthcare Buyers and Sellers at HIMSS19

    TAMPA, FL, Feb. 07, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated healthcare platform, announced today its participation in the Healthcare.

  • GlobeNewswire

    Trxade Group and PanOptic Health to Launch SyncHealth Joint Venture

    A Revolutionary Technology Solution to Empower Independent Retail Pharmacies TAMPA, FL, Jan. 22, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an.

  • GlobeNewswire

    Trxade Group Engages Hayden IR to Launch Comprehensive Investor Relations Program

    Focused on Increasing Awareness and Enhancing Shareholder Value TAMPA, FL, Jan. 03, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), a web-based.

  • ACCESSWIRE

    Trxade Group, Inc to Present at the 11th Annual LD Micro Main Event

    LOS ANGELES, CA / ACCESSWIRE / November 19, 2018 / Trxade Group, Inc., ( OTCQB: TRXD ) the trusted B2B market place for 9,300 registered independent pharmacy customers that enables its customers to quickly ...

  • GlobeNewswire

    Trxade Group, Inc. Reports Third Quarter Fiscal 2018 Results

    Achieved 15% Revenue growth from year-over-year periods and the seventh consecutive quarter of positive operating incomeCompleted a strategic acquisition of a retail specialty.

  • ACCESSWIRE

    TRxADE GROUP, INC. Announces Acquisition of Independent Specialty Pharmacy

    TAMPA, FL / ACCESSWIRE / October 16, 2018 / Trxade Group, Inc., ( OTCQB: TRXD ) a web-based pharmaceutical sourcing and purchasing platform with 9,300 registered independent pharmacy customers that procure ...

  • ACCESSWIRE

    TRxADE GROUP, INC. Launches New Enhancements to Trading Platform

    TAMPA, FL / ACCESSWIRE / October 2, 2018 / Trxade Group, Inc., (OTCQB: TRXD) a web-based market platform with 9,300 registered independent pharmacy customers that enables its customers to quickly source and purchase pharmaceuticals, accessories and services from a wide range of manufacturers and drug distributors today announced new enhancements to the trading platform. Jariel Morales, Executive Vice President of Trxade Group said, "As we continue on our path of being a premier healthcare solutions provider, our team has focused on the voice of the customer and expanding our portfolio to provide additional services to our members that increase their bottom line revenue, increase the number of patients they see each month, and provide alternative health solutions to their patient base. New and advanced filters allowing members to select VAWD, VAWD Pending, or Non-VAWD Suppliers and filter their favorite products by Brand or Generic.